Monday, March 1, 2021

Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand

Cipla Gulf expands partnership with Alvotech for commercialisation of four drugs in Australia, New Zealand Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand, the company said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3dX2Pzp
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Network18 Q4 loss at Rs 29.61 crore, revenue up 9.7% to Rs 615.78 cr

Network18 Media & Investments reported a consolidated net loss of Rs 29.61 crore for the March quarter, despite a 9.7% rise in operation...